Forgot to put this link with Larry Glass's presentation from an Angelman summit in 2019, which describes NNZ2591 and Trofinetide inside the brain,
many thanks to hottod for posting it
NEUREN PHARMACEUTICALS LIMITED (ASX:NEU) - Angelman syndrome, 42157741, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum
Updated MST report - target of $3.68 a share, page-40
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $5.043M | 365.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $13.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |